Spruce Point Capital – Caesarstone Ltd (CSTE) – Nothing On The CounterGuest Post
Spruce Point Capital Management wants to alert our readers to a new research report on Caesarstone (Nasdaq: CSTE) by an independent firm called Viceroy Research, which was released earlier today. We believe this report strengthens our views that CSTE is at best a $15 stock.
- CSTE’s major revenue growth product, marketed as a collaboration with Lowe’s, is not for sale according to Lowe’s Customer Services and store checks. This is contrary sell-side forecasts highlighting this as a growth driver.
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.